Impact of two formulas to calculate percentage diameter stenosis of coronary lesions: from stenosis models (phantom lesion model) to actual clinical lesions.


Journal

The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 12 04 2019
accepted: 17 07 2019
pubmed: 29 7 2019
medline: 22 1 2020
entrez: 29 7 2019
Statut: ppublish

Résumé

Percentage diameter stenosis (%DS) by angiography is still commonly used to determine luminal obstruction of coronary artery disease (CAD) lesions. While visual estimation of %DS is widespread, because of high inter-operator variability, quantitative coronary arteriography (QCA) analysis is the gold standard. There are two %DS formulas: %DS1 averages the proximal and distal reference vessel diameter (RVD); %DS2 interpolates the RVD. This study aims to evaluate the difference between %DS assessed by QCA in two datasets, phantom lesion models and CAD patients. Ten phantom lesion models (PLMs) and 354 CAD lesions from the FIRST trial were assessed by QCA. In the latter, two scenarios were assessed: Scenario A (worst view), the most common approach in the clinical setting; and Scenario B (average of two complementary views), the standard core-laboratory analysis. In the PLMs, %DS1 and %DS2 mean ± standard deviation (median) was 58.5 ± 21.7 (61.6) and 58.7 ± 21.6 (61.8), respectively, with a signed difference of - 0.2% ± 0.3% (- 0.1%). In Scenario A, the mean %DS1 was 43.8 ± 9.1 (43.3) and 44.0 ± 9.1 (42 .9) in %DS2. In Scenario B, the mean %DS1 was 45.3 ± 8.8 (45.1) and 45.5 ± 9.0 (45.1) in %DS2. The signed difference was - 0.2% ± 2.4% (0.0%) and - 0.2% ± 2.1% (0.0%) in Scenario A and B, respectively. These differences between formulas ranged from - 1.2 to 0.5% for the phantom cases compared to - 17.7% to 7.7% in Scenario A and to - 15.5% to 7.1% in Scenario B. Although the overall means of the formulas provide similar results, significant lesion-level differences are observed. The use of the worst view versus the average of two views provided similar results.

Identifiants

pubmed: 31352559
doi: 10.1007/s10554-019-01672-z
pii: 10.1007/s10554-019-01672-z
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2139-2146

Références

J Am Coll Cardiol. 1991 Oct;18(4):945-51
pubmed: 1894868
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241
pubmed: 28291663
Am Heart J. 1990 Jan;119(1):178-84
pubmed: 2404387
Circulation. 1979 Jul;60(1):106-13
pubmed: 445713
J Am Coll Cardiol. 2017 Feb 7;69(5):570-591
pubmed: 28012615
J Am Coll Cardiol. 1988 Apr;11(4):882-5
pubmed: 3280642
Circulation. 1976 Apr;53(4):627-32
pubmed: 1253383
IEEE Trans Med Imaging. 1984;3(3):131-41
pubmed: 18234621
Circulation. 1995 Oct 1;92(7):1994-2000
pubmed: 7671382
Circ Cardiovasc Interv. 2014 Dec;7(6):751-9
pubmed: 25336468
Am J Cardiol. 1990 May 15;65(18):1181-4
pubmed: 2337026
Circulation. 1988 Feb;77(2):484-90
pubmed: 3276411
J Am Coll Cardiol. 2013 Mar 5;61(9):917-23
pubmed: 23352786

Auteurs

Alexandre Hideo-Kajita (A)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Samuel Wopperer (S)

Georgetown University School of Medicine, Washington, USA.

Solomon S Beyene (SS)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Yael F Meirovich (YF)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Gebremedhin D Melaku (GD)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Kayode O Kuku (KO)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Echo J Brathwaite (EJ)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Yuichi Ozaki (Y)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Kazuhiro Dan (K)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Rebecca Torguson (R)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Ron Waksman (R)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA.

Hector M Garcia-Garcia (HM)

Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, Washington, USA. hector.m.garciagarcia@medstar.net.
Division of Interventional Cardiology - MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Georgetown University, East Building - Room 5121, 110 Irving St NW, Washington, DC, 20010, USA. hector.m.garciagarcia@medstar.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH